PharmaCyte Biotech Inc (PMCB)

[Triple9]

Dr. Hidalgo, MD, PhD, is going to be our Principal Investigator and he is just incredible!

On Sept 6th $PMCB IR noted that KW was in Boston:

This picture was not taken in Boston. It was only uploaded while the CEO is in Boston to meet with Dr. Hidalgo, who is the Principal Investigator for the company's upcoming pivotal clinical trial in LAPC.

https://www.facebook.com/pharmacytebiotech/photos/pb.404679473033875.-2207520000.1505666302./838601716308313/?type=3&theater

Dr. Hidalgo, MD, PhD, is:

an "International leader in pancreatic cancer research and treatment" [1]

Connected to 67 various biotech, cancer treatment, and medical research Board of Directors [2]

A Professor at Harvard Medical School [3]

Member of Dana-Farber Harvard Cancer Center [3]

Chief of Hematology Oncology at the Beth Israel Deaconess Medical Center [3]

Director of Rosenberg Clinical Cancer Center at the Beth Israel Deaconess Medical Center [3]

Co-Director of the Pancreatic Cancer Research Program at the Beth Israel Deaconess Medical Center [3]

[1] http://www.bidmc.org/News/PRLandingPage/2015/October/Hidalgo.aspx

[2] http://www.bloomberg.com/research/stocks/people/relationship.asp?personId=12401156

[3] http://www.dfhcc.harvard.edu/insider/member-detail/member/manuel-hidalgo-md-phd/

Here is one of Dr. Hidalgo's, MD, PhD, co-authored, peer-reviewed publications on "Evaluation of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Kinase Inhibitor, in Patients With Advanced Solid Tumors Harboring Genetic Alterations in Fibroblast Growth Factor Receptors: Results of a Global Phase I, Dose-Escalation and Dose-Expansion Study" from January 2017.

https://www.ncbi.nlm.nih.gov/pubmed/27870574

Go $PMCB!